The bitter end: the ubiquitin-proteasome system and cardiac dysfunction

Area of Science:

• Cardiology
• Molecular Biology
• Biochemistry

Background:

• Congestive heart failure (CHF) involves complex factors like altered perfusion, hemodynamics, calcium metabolism, and cell signaling.
• Current therapies for CHF often fail to normalize cardiac function, highlighting a need for novel approaches.
• Proteins are susceptible to damage in the heart due to their roles in stress sensing and force generation.

Purpose of the Study:

• To review the role of protein damage and impaired clearance in the pathophysiology of heart failure.
• To explore the mechanisms of protein quality control (PQC) in cardiac cells.
• To discuss the potential of PQC strategies for novel heart failure prevention and treatment.

Main Methods:

• Literature review of existing research on protein damage, clearance, and PQC in heart failure.
• Analysis of the molecular chaperone and ubiquitin-proteasome systems in cardiac PQC.
• Synthesis of findings to provide a clinically oriented understanding of PQC in heart failure.

Main Results:

• Evidence suggests protein damage and reduced clearance contribute to heart failure progression.
• The molecular chaperone and ubiquitin-proteasome systems are key effectors of cardiac PQC.
• Dysregulation of PQC pathways is implicated in human heart failure syndromes.

Conclusions:

• Protein damage and impaired clearance are critical in heart failure pathophysiology.
• Enhancing protein quality control mechanisms presents a promising therapeutic avenue for heart failure.
• Further research into PQC pathways could lead to innovative treatments and preventive strategies for CHF.